Report cover image

Global Companion Animal Vaccine Market Size & Share to 2027

Publisher QualiKet Research
Published Apr 29, 2022
Length 167 Pages
SKU # QUA17148440

Description

Global Companion Animal Vaccine Market Size & Share to 2027

Global Companion Animal Vaccine Market Size, Trends & Growth Opportunity, By Product Type (Conjugate Vaccine, Attenuated Live Vaccine, Inactivated Vaccine, Toxoid Vaccine, Subunit Vaccine, , DNA Vaccine, and Recombinant Vaccine), By Animal Type (Canine, Feline, Equine, and Others), By Distribution Channel, By Region and Forecast till 2027.

Global Companion Animal Vaccine Market

Veterinary vaccines play vital role in improving the health of companion animals. They are also important for reducing viral diseases transmitted from animals to animals as well as animals to humans. These vaccines are categorized into various product types such as Attenuated Live Vaccine, Conjugate Vaccine, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, DNA Vaccine, and Recombinant Vaccine.

Market Drivers

The rise in product approval activities is the key driving factor which is expected to boost the global companion animal vaccine market growth. For instance, in May 2020, Merck & Co., Inc had launched new vaccine known as NOBIVAC Myxo-RHD PLUS vaccine which is used to decrease mortality due to common viral diseases in rabbits like myxomatosis and rabbit haemorrhagic disease (RHD).Furthermore, increase in mergers and acquisitions by key players will positively contribute the market growth. For instance, in July 2019, Elanco Animal Health Incorporated had announced acquisition or Aratana Therapeutics for development and commercialization of innovative therapeutics for dogs and cats. Moreover, rise in product launch activities is expected to fuel the global companion animal vaccine market growth. In addition to that, increase in initiatives from regulatory authorities for prevention of diseases like viral diseases in companion animal which may drive the market growth during this forecast period. For instance, as per the American Animal Hospital Association has commissioned a task force of veterinary experts for development of guidelines which will help veterinary teams to work with pet owners for treatment plans that will improve the quality of life of pets with cancer.

Market Restraints

Increase in cost for storage of vaccines and inadequate reporting systems is major restraining factors for market growth which is expected to hamper the global companion animal vaccine market growth during this forecast timeline.

Market Segmentation

Global Companion Animal Vaccine Market is segmented into product type such as Conjugate Vaccine, Attenuated Live Vaccine, Inactivated Vaccine, Toxoid Vaccine, Subunit Vaccine, DNA Vaccine, and Recombinant Vaccine, by animal type such as Canine, Feline, Equine, and Others. Further, market is segmented into distribution channel such as Veterinary Hospitals, and Veterinary Research Institutes.

Also, Global Companion Animal Vaccine Market is segmented various regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Market Key Players

Various key players are discussed in this report such as Boehringer Ingelheim GmbH, Elanco Animal Health Incorporated, Ceva, Merck & Co., Inc, Virbac, Zoetis Inc, Biogénesis Bagó, Ourofino Animal Health,and HIPRA

Market Taxonomy

By Product Type
  • Conjugate Vaccine
  • Attenuated Live Vaccine
  • Inactivated Vaccine
  • Toxoid Vaccine
  • Subunit Vaccine
  • DNA Vaccine
  • Recombinant Vaccine
By Animal Type
  • Canine
  • Feline
  • Equine
  • Others
By Distribution Channel
  • Veterinary Hospitals
  • Veterinary Research Institutes
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Key Questions Addressed by the Report
  • What are the Key Opportunities in Global Companion Animal Vaccine Market?
  • What will be the growth rate from 2019 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?

Table of Contents

167 Pages
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Companion Animal Vaccine Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Companion Animal Vaccine Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Companion Animal Vaccine Market Share Analysis, By Product Type
5.3 Global Companion Animal Vaccine Market Size and Forecast, By Product Type
5.3.1 Conjugate Vaccine
5.3.2 Attenuated Live Vaccine
5.3.3 Inactivated Vaccine
5.3.4 Toxoid Vaccine
5.3.5 Subunit Vaccine
5.3.6 DNA Vaccine
5.3.7 Recombinant Vaccine
6 Global Companion Animal Vaccine Market, By Animal Type
6.1 Y-o-Y Growth Comparison, By Animal Type
6.2 Global Companion Animal Vaccine Market Share Analysis, By Animal Type
6.3 Global Companion Animal Vaccine Market Size and Forecast, By Animal Type
6.3.1 Canine
6.3.2 Feline
6.3.3 Equine
6.3.4 Others
7 Global Companion Animal Vaccine Market, By Distribution Channel
7.1 Y-o-Y Growth Comparison, By Distribution Channel
7.2 Global Companion Animal Vaccine Market Share Analysis, By Distribution Channel
7.3 Global Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
7.3.1 Veterinary Hospital
7.3.2. Veterinary Research Institution
8 Global Companion Animal Vaccine Market, By Region
8.1 Global Companion Animal Vaccine Market Share Analysis, By Region
8.2 Global Companion Animal Vaccine Market Share Analysis, By Region
8.3 Global Companion Animal Vaccine Market Size and Forecast, By Region
9 North America Companion Animal Vaccine Market Analysis and Forecast (2020-2027)
9.1 Introduction
9.2 North America Companion Animal Vaccine Market Share Analysis, By Product Type
9.3 North America Companion Animal Vaccine Market Size and Forecast, By Animal Type
9.4 North America Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
9.5 North America Companion Animal Vaccine Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 EuropeCompanion Animal Vaccine Market Analysis and Forecast (2020-2027)
10.1 Introduction
10.2 Europe Companion Animal Vaccine Market Share Analysis, By Product Type
10.3 Europe Companion Animal Vaccine Market Size and Forecast, By Animal Type
10.4 Europe Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
10.5 Europe Companion Animal Vaccine Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Companion Animal Vaccine Market Analysis and Forecast (2020-2027)
11.1 Introduction
11.2 Asia Pacific Companion Animal Vaccine Market Share Analysis, By Product Type
11.3 Asia Pacific Companion Animal Vaccine Market Size and Forecast, By Animal Type
11.4 Asia Pacific Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
11.5 Asia Pacific Companion Animal Vaccine Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Companion Animal Vaccine Market Analysis and Forecast (2020-2027)
12.1 Introduction
12.2 Latin America Companion Animal Vaccine Market Share Analysis, By Product Type
12.3 Latin America Companion Animal Vaccine Market Size and Forecast, By Animal Type
12.4 Latin America Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
12.5 Latin America Companion Animal Vaccine Market Size and Forecast, Country
13 Middle East Companion Animal Vaccine Market Analysis and Forecast (2020-2027)
13.1 Introduction
13.2 Middle East Companion Animal Vaccine Market Share Analysis, By Product Type
13.3 Middle East Companion Animal Vaccine Market Size and Forecast, By Animal Type
13.4 Middle East Companion Animal Vaccine Market Size and Forecast, By Distribution Channel
13.5 Middle East Companion Animal Vaccine Market Size and Forecast, By Country
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Boehringer Ingelheim GmbH
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Elanco Animal Health Incorporated
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Ceva
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Merck & Co., Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Virbac
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Zoetis Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Biogénesis Bagó
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Ourofino Animal Health
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 HIPRA
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us